| http://www.w3.org/ns/prov#value | - cravings.More importantly, Mugnaini said, the brain imaging studies suggested that higher doses of GSK598809 than those used in the human tests may be more effective at reducing smokers' cravings.The study's findings were published in the journal Neuropsychopharmacology on Wednesday.Several drugs are already on the market to help smokers quit, including Pfizer's Chantix or Champix, and GSK's Zyba
|
